KIT and intrahepatic cholangiocarcinoma: For example, in some GI pathologies that cause digestive dysmotility, ICC lose their expression of KIT, making KIT antibodies a poor marker of ICC as they cannot be used to track ICC that undergo phenotypic alterations26.